Bench To Bedside And FDA Submission Strategies For Cell And Gene Therapies

By Dr. Wilson Bryan, director at the Office of Tissues and Advanced Therapies, FDA, Dr. Alison Moore, Chief Technology Officer at Allogene Therapeutics, Dr. Hari Pujar, operating partner at Flagship Pioneering, Dr. Greg Russotti, Chief Technology Officer at Century Therapeutics, Dr. Dolores Baksh, global solutions marketing leader for Cytiva’s cell therapy business